Korean Biotech Industry Begins to Develop CAR-T Therapeutic Drug – BusinessKorea
BusinessKorea |
Korean Biotech Industry Begins to Develop CAR–T Therapeutic Drug
BusinessKorea The Korean biotech industry joined competition to develop a chimeric antigen receptor-T cell (CAR-T) therapeutic drug called “the cancer drug of doctors' dream.” CAR-T is a technology that allows T cells which are a kind of common immune cells in blood … |
